ORDERING INFORMATION

Catalog No.

Clone No.

MAb Subtype

Size

Library Pack No.

100ug/clone

16601

LC10-136.4

IgG1

100ug, 500ug

166101

All 5 clones

16602

LC11-222.4

IgG1

100ug, 500ug

16603

LC11-251.3.6

IgG1

100ug, 500ug

16604

LC11-378.5

IgG1

100ug, 500ug

16605

LC12-402.3

IgG1

100ug, 500ug

Format: Protein G-purified antibody in PBS, pH 7.4.

BACKGROUND

Lidocaine, also known as xylocaine and lignocaine, is a medication used to numb tissue in a specific area. The efficacy of lidocaine as a local anesthetic is characterized by a rapid onset of action and intermediate duration of efficacy. Lidocaine is also the most important class-1b antiarrhythmic drug; it is used intravenously for the treatment of ventricular arrhythmias. Lidocaine was discovered in 1946 and is on the WHO Model List of Essential Medicines.

SPECIFICATION SUMMARY

Antigen: Lidocaine conjugated to KLH.

Host Species: Mouse

Specificity: These antibodies recognize lidocaine.

APPLICATIONS

These antibodies have been qualified for use in ELISA to detect lidocaine.

DILUTION INSTRUCTIONS

Dilute in PBS or medium that is identical to that used in the assay system.

STORAGE AND STABILITY

These antibodies are stable for at least one (1) year at -20oC to -70oC. Store product in appropriate aliquots to avoid multiple freeze-thaw cycles.

For in vitro investigational use only. Not for use in therapeutic or diagnostic procedures.